Search Results 531-540 of 15136 for alt

1. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

   AST/ALT > 2.5x upper limit normal 14. Presence of significant liver disease with total bilirubin > 2X upper limit or as per clinical judgment 15. Inability ...

2. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

   aminotransferase, AST/ALT) and alkaline phosphatase ≤ 3 (≤ 5 X the upper limit of normal (ULN) in the setting of liver metastasis or infiltration with ...

3. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

   ... (ALT) ≤ 3.0 × ULN, and albumin ≥ 3.0 g/dL;; Hepatic function for subjects with liver metastases: bilirubin ≤ 1.5 × ULN, AST, ALT, and GGT ≤ 5.0 × ULN ...

4. Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy - Mayo Clinic

   AST or ALT < 2.5 times ULN for age; Not pregnant or nursing; Negative pregnancy test (if patient has child-bearing capacity); Fertile patients must use ...

5. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Participation eligibility · AST or ALT > 2.5 x ULN; · Total bilirubin ≥ 1.5 x ULN; · INR > 1.5 x ULN in the absence of therapeutic anticoagulation; · PTT or aPTT > ...

6. Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma - Mayo Clinic

   Hepatic: bilirubin <1.5 X Upper Limit of Normal (ULN); alkaline phosphatase (ALP), alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < 5.0 X ...

7. A Study to Evaluate the Effectiveness of Acetazolamide to Treat Patients with Ataxia in PMM2-Congenital Disorder of Glycosylation - Mayo Clinic

   Participation eligibility · Hepatic impairment defined as AST/ALT > 5 x ULN in the last 12 months. · Renal impairment defined as serum creatinine 1.5-1.9 x ULN ...

8. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 × ULN; AST and ALT ≤ 5 × ULN if liver metastases are present.. Serum creatinine ...

9. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

   ... [ALT]) =< 3 x ULN or SGOT (AST) and SGPT (ALT) =< 5 x ULN is acceptable if liver has tumor involvement; Obtained =< 14 days prior to registration: Creatinine ...

10. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

    AMKL PATIENTS: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN. AMKL PATIENTS: Creatinine < 1.5 x ULN or calculated creatinine ...